Intra-articular Injectable Therapies.
Franklin SP and Kieves N. Canine and Feline Arthroscopy. Editors Franklin SP, Pozzi A, Schulz KS. Elsevier. Publication expected 2025.
Randomized Controlled Trial Comparing Autologous Protein Solution to Hyaluronic Acid Plus Triamcinolone for Treating Hip Osteoarthritis in Dogs
Franklin, SP. Frontiers in Veterinary Science 2021 PMID: 34395580 PMCID: PMC8357414 DOI: 10.3389/fvets.2021.713768
A Pilot Clinical Study Assessing Treatment of Canine Hip Dysplasia using Autologous Protein Solution.
Franklin, SP. Frontiers in Veterinary Science 2019; 6:243 doi.org/10.3389/fvets.2019.00243
Biological Therapies in Canine Sports Medicine.
Pozzi A and Franklin SP. In Canine Sports Medicine and Rehabilitation. Second Edition. Editors Chris Zink and Janet B. Van Dyke. John Wiley & Sons, Inc. 2018. Chapter 16; pages 404-424.
Platelet-rich plasma and autologous conditioned serum.
Saunders B, Bearden R, and Franklin SP. In Veterinary Surgery: Small Animal. Second Edition. Editors KM Tobias and SA Johnston. Elsevier Health Sciences. 2018. Chapter 4; pages 40-48.
Assessment of Canine Autologous Conditioned Plasma™ Cellular and Transforming Growth Factor-β1 Content.
Franklin SP, Birdwhistell KE. Frontiers in Veterinary Science. 2018;11(5):105. doi: 10.3389/fvets.2018.00105
Use of a cyclooxygenase-2 inhibitor does not inhibit platelet activation or growth factor release from platelet-rich plasma.
Ludwig HC, Brainard BM, Birdwhistell KE, Franklin SP. American Journal of Sports Medicine. 2017;45(14):3351-3357.
doi: 10.1177/0363546517730578
Sustained release of transforming growth factor-β1 from platelet-rich chondroitin sulfate glycosaminoglycan gels.
Birdwhistell KE, Karumbaiah L, Franklin SP. Journal of Knee Surgery. 2017.
doi: 10.1055/s-0037-1603801.
The effect of platelet-rich plasma on osseous healing in dogs undergoing high tibial osteotomy.
Franklin SP, Burke E, Holmes SP. PLoS One. 2017; May 16;12(5):e0177597.
doi: 10.1371/journal.pone.0177597.
Influence of Cellular Composition and Exogenous Activation on Growth Factor and Cytokine Concentrations in Canine Platelet-Rich Plasmas.
Franklin SP, Birdwhistell KE, Strelchik A, Garner BC, and Brainard B. Frontiers in Veterinary Science. April 5, 2017. https://doi.org/10.3389/fvets.2017.00040
Validation of commercial ELISAS for quantifying anabolic growth factors and cytokines in canine ACD-A anticoagulated plasma.
Birdwhistell KE, Basinger RW, Hayes BR, Norton NA, Hurley DJ, Franklin SP. Journal of Veterinary Diagnostic Investigation. 2017 Mar;29(2):143-147
doi: 10.1177/1040638717690186.
Characteristics of canine platelet-rich plasma prepared with five commercially available systems.
Franklin SP, Garner BC, and Cook JL. American Journal of Veterinary Research, 2015; 76:822–827.
Prospective trial of autologous conditioned plasma versus hyaluronan plus corticosteroid for elbow osteoarthritis in dogs.
Franklin SP and Cook JL. Canadian Veterinary Journal, 2013;54(9):881-884.
